1 - 25 of 272 results for author:"Imai Y." in Literature citations
Results Customize
› Repeat search in UniProtKB (339)
| Vitamin D receptor in osteoblasts is a negative regulator of bone mass control. Yamamoto Y., Yoshizawa T., Fukuda T., Shirode-Fukuda Y., Yu T., Sekine K., Sato T., Kawano H., Aihara K., Nakamichi Y. et al. Endocrinology 154:1008-1020(2013) · Mapped (3) |
| Tricornered/NDR kinase signaling mediates PINK1-directed mitochondrial quality control and tissue maintenance. Wu Z., Sawada T., Shiba K., Liu S., Kanao T., Takahashi R., Hattori N., Imai Y., Lu B. Genes Dev. 27:157-162(2013) · Mapped (10) |
| CXCL10-CXCR3 enhances the development of neutrophil-mediated fulminant lung injury of viral and nonviral origin. Ichikawa A., Kuba K., Morita M., Chida S., Tezuka H., Hara H., Sasaki T., Ohteki T., Ranieri V.M., dos Santos C.C. et al. Am. J. Respir. Crit. Care Med. 187:65-77(2013) · Mapped (1) |
| Low-energy extracorporeal shock wave therapy enhances skin wound healing in diabetic mice: a critical role of endothelial nitric oxide synthase. Hayashi D., Kawakami K., Ito K., Ishii K., Tanno H., Imai Y., Kanno E., Maruyama R., Shimokawa H., Tachi M. Wound Repair Regen 20:887-895(2012) · Mapped (3) |
| Effects of perilipin 2 antisense oligonucleotide treatment on hepatic lipid metabolism and gene expression. Imai Y., Boyle S., Varela G.M., Caron E., Yin X., Dhir R., Dhir R., Graham M.J., Ahima R.S. Physiol. Genomics 44:1125-1131(2012) · Mapped (7) |
| The synaptic function of LRRK2. Lee S., Imai Y., Gehrke S., Liu S., Lu B. Biochem. Soc. Trans. 40:1047-1051(2012) · Mapped (5) |
| Genetic polymorphisms of the human PNPLA3 gene are strongly associated with severity of non-alcoholic fatty liver disease in Japanese. Kawaguchi T., Sumida Y., Umemura A., Matsuo K., Takahashi M., Takamura T., Yasui K., Saibara T., Hashimoto E., Kawanaka M. et al. PLoS ONE 7:e38322-e38322(2012) · Mapped (1) |
| Reduced PLP1 expression in induced pluripotent stem cells derived from a Pelizaeus-Merzbacher disease patient with a partial PLP1 duplication. Shimojima K., Inoue T., Imai Y., Arai Y., Komoike Y., Sugawara M., Fujita T., Ideguchi H., Yasumoto S., Kanno H. et al. J. Hum. Genet. 57:580-586(2012) · Mapped (7) |
| Multiple phosphorylation sites are important for RUNX1 activity in early hematopoiesis and T-cell differentiation. Yoshimi M., Goyama S., Kawazu M., Nakagawa M., Ichikawa M., Imai Y., Kumano K., Asai T., Mulloy J.C., Kraft A.S. et al. Eur. J. Immunol. 42:1044-1050(2012) · Mapped (6) |
| Integration of pro-inflammatory cytokines, 12-lipoxygenase and NOX-1 in pancreatic islet beta cell dysfunction. Weaver J.R., Holman T.R., Imai Y., Jadhav A., Kenyon V., Maloney D.J., Nadler J.L., Rai G., Simeonov A., Taylor-Fishwick D.A. Mol. Cell. Endocrinol. 358:88-95(2012) · Mapped (14) |
| Mutations affecting components of the SWI/SNF complex cause Coffin-Siris syndrome. Tsurusaki Y., Okamoto N., Ohashi H., Kosho T., Imai Y., Hibi-Ko Y., Kaname T., Naritomi K., Kawame H., Wakui K. et al. Nat. Genet. 44:376-378(2012) · UniProtKB (6) |
| Parkinson's disease-associated kinase PINK1 regulates Miro protein level and axonal transport of mitochondria. Liu S., Sawada T., Lee S., Yu W., Silverio G., Alapatt P., Millan I., Shen A., Saxton W., Kanao T. et al. PLoS Genet. 8:e1002537-e1002537(2012) · Mapped (7) |
| The nitric oxide-cyclic GMP pathway regulates FoxO and alters dopaminergic neuron survival in Drosophila. Kanao T., Sawada T., Davies S.A., Ichinose H., Hasegawa K., Takahashi R., Hattori N., Imai Y. PLoS ONE 7:e30958-e30958(2012) · Mapped (31) |
| JMJD5, a Jumonji C (JmjC) domain-containing protein, negatively regulates osteoclastogenesis by facilitating NFATc1 protein degradation. Youn M.Y., Yokoyama A., Fujiyama-Nakamura S., Ohtake F., Minehata K., Yasuda H., Suzuki T., Kato S., Imai Y. J. Biol. Chem. 287:12994-13004(2012) · Mapped (13) |
| Knocking-in the R142C mutation in transglutaminase 1 disrupts the stratum corneum barrier and postnatal survival of mice. Nakagawa N., Yamamoto M., Imai Y., Sakaguchi Y., Takizawa T., Ohta N., Yagi N., Hatta I., Hitomi K., Takizawa T. et al. J. Dermatol. Sci. 65:196-206(2012) · Mapped (1) |
| DNA damage signaling triggers degradation of histone methyltransferases through APC/C(Cdh1) in senescent cells. Takahashi A., Imai Y., Yamakoshi K., Kuninaka S., Ohtani N., Yoshimoto S., Hori S., Tachibana M., Anderton E., Takeuchi T. et al. Mol. Cell 45:123-131(2012) · Mapped (6) |
| GlcNAcylation of histone H2B facilitates its monoubiquitination. Fujiki R., Hashiba W., Sekine H., Yokoyama A., Chikanishi T., Ito S., Imai Y., Kim J., He H.H., Igarashi K. et al. Nature 480:557-560(2011) · UniProtKB (3) |
| Evi1 is essential for hematopoietic stem cell self-renewal, and its expression marks hematopoietic cells with long-term multilineage repopulating activity. Kataoka K., Sato T., Yoshimi A., Goyama S., Tsuruta T., Kobayashi H., Shimabe M., Arai S., Nakagawa M., Imai Y. et al. J. Exp. Med. 208:2403-2416(2011) · Mapped (17) |
| AML1/RUNX1 functions as a cytoplasmic attenuator of NF-kappaB signaling in the repression of myeloid tumors. Nakagawa M., Shimabe M., Watanabe-Okochi N., Arai S., Yoshimi A., Shinohara A., Nishimoto N., Kataoka K., Sato T., Kumano K. et al. Blood 118:6626-6637(2011) · Mapped (11) |
| Influence of adrenomedullin 2/intermedin gene polymorphism on blood pressure, renal function and silent cerebrovascular lesions in Japanese: the Ohasama study. Hirose T., Totsune K., Nakashige Y., Metoki H., Kikuya M., Ohkubo T., Hara A., Satoh M., Inoue R., Asayama K. et al. Hypertens. Res. 34:1327-1332(2011) · Mapped (3) |
| Conditional deletion of Bmpr1a in differentiated osteoclasts increases osteoblastic bone formation, increasing volume of remodeling bone in mice. Okamoto M., Murai J., Imai Y., Ikegami D., Kamiya N., Kato S., Mishina Y., Yoshikawa H., Tsumaki N. J. Bone Miner. Res. 26:2511-2522(2011) · Mapped (3) |
| YKL-40 (chitinase 3-like-1) as a biomarker for psoriasis vulgaris and pustular psoriasis. Imai Y., Tsuda T., Aochi S., Futatsugi-Yumikura S., Sakaguchi Y., Nakagawa N., Iwatsuki K., Yamanishi K. J. Dermatol. Sci. 64:75-77(2011) · Mapped (4) |
| Loss of AML1/Runx1 accelerates the development of MLL-ENL leukemia through down-regulation of p19ARF. Nishimoto N., Arai S., Ichikawa M., Nakagawa M., Goyama S., Kumano K., Takahashi T., Kamikubo Y., Imai Y., Kurokawa M. Blood 118:2541-2550(2011) · Mapped (13) |
| Targeting androgen receptor in estrogen receptor-negative breast cancer. Ni M., Chen Y., Lim E., Wimberly H., Bailey S.T., Imai Y., Rimm D.L., Liu X.S., Brown M. Cancer Cell 20:119-131(2011) · Mapped (67) |
| PKA-dependent regulation of the histone lysine demethylase complex PHF2-ARID5B. Baba A., Ohtake F., Okuno Y., Yokota K., Okada M., Imai Y., Ni M., Meyer C.A., Igarashi K., Kanno J. et al. Nat. Cell Biol. 13:668-675(2011) · UniProtKB (2) · Mapped (2) |